Amgen (AMGN) Beats Q2 Earnings Estimates, to Buy Chemocentryx

This article was originally published on Nasdaq

Amgen AMGN reported second-quarter 2022 earnings of $4.65 per share, which beat the Zacks Consensus Estimate of $4.40. In the year-ago quarter, earnings were $1.77 per share. Lower operating expenses and share count boosted earnings in the quarter.

Responses